Hypophosphatemic osteomalacia: A report of five cases and evaluation of bone markers

Journal of Bone and Mineral Metabolism

Volumn 23, Issue 3, 2005, Pages 266-269

  Ros, Inmaculada ^a   Alvarez, Luisa ^a   Guañabens, Nuria ^a   Peris, Pilar ^a   Monegal, Ana ^a   Vázquez, Ivonne ^a   Cerdá, Dacia ^a   Ballesta, Antonio M ^a   Muñoz Gómez, José ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Alkaline phosphatase; Bone turnover; CTX; NTX; Osteocalcin; PINP

Indexed keywords

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; HYDROXYPROLINE; METALLOPROTEINASE; OSTEOCALCIN; PROCOLLAGEN TYPE 1 N PROPEPTIDE; UNCLASSIFIED DRUG;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE BIOPSY; BONE TURNOVER; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HYDROXYPROLINE URINE LEVEL; HYPOPHOSPHATEMIA; LABORATORY DIAGNOSIS; MALE; OBSERVER VARIATION; OSSIFICATION; OSTEOLYSIS; OSTEOMALACIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE AND BONES; FEMALE; HUMANS; HYPOPHOSPHATEMIA; MALE; MIDDLE AGED; MINERALS; OSTEOMALACIA;

EID: 18044392048     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-004-0594-z     Document Type: Article

References (14)

1. Glorieux FH (2003) Hypophosphatemic vitamin D-resistant rickets. In: Favus MJ (ed) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 5th ed. American Society for Bone and Mineral Research, Washington, DC, pp 414-417
2. Bingham CT, Fritzpatrick LA (1993) Non-invasive testing in the diagnosis of osteomalacia. Am J Med 95:519-523
3. Reginato AJ, Falasca GF, Pappu R, McKnight B, Agha A (1999) Musculoskeletal manifestations of osteomalacia: report of 26 cases and literature review. Semin Arthritis Rheum 28:287-304
4. Bisballe S, Ericksen EF, Meisen F, Mosekilde L, Sorensen H, Hessov I (1991) Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers and bone remodeling, vitamin D metabolites and bone histomorphometry. Gut 32:1303-1307
5. Li F, Iqbal J, Wassif W, Kaddam I, Moniz C (1994) Carboxyterminal propeptide of type I procollagen in osteomalacia. Calcif Tissue Int 55:90-93
6. Demiaux B, Arlot ME, Chapuy M-C, Meunier PJ, Delmas PD (1992) Serum osteocalcin is increased in patients with osteomalacia: correlations with biochemical and histomorphometric findings. J Clin Endocrinol Metab 74:1146-1151
7. Charles P, Hasling C, Risteli L, Risteli J, Mosekilde L, Eriksen EF (1992) Assessment of bone formation by biochemical markers in metabolic bone disease: separation between osteoblastic activity at the cell and tissue level. Calcif Tissue Int 51:406-411
8. 3. J Clin Endocrinol Metab 56:1063-1067
9. Sharp CA, Oginni LM, Worsfold M, Oyelami OA, Risteli L, Risteli J, Davie MWJ (1997) Elevated collagen turnover in Nigerian children with calcium-deficiency rickets. Calcif Tissue Int 61:87-94
10. Shane E, Parisien M, Henderson JE, Dempster DW, Feldman F, Hardy MA, Tohme JF, Karaplis AC, Clemens TL (1997) Tumor-induced osteomalacia: clinical and basic studies. J Bone Miner Res 12:1502-1511
11. Fledelius C, Johnsen AH, Cloos PAC, Bonde M, Qvist P (1997) Characterization of urinary degradation products derived from type I collagen. J Biol Chem 272:9755-9763
12. Garnero P, Fledelius C, Gineyts E, Serre CM, Vignot E, Delmas P (1997) Decreased β-isomerization of the C-terminal telopeptide of type I collagen a 1 chain in Paget's disease of bone. J Bone Miner Res 12:1407-1415
13. Hoshino H, Takahashi M, Kushida K, Ohishi T, Inoue T (1999) The relationships between the degrees of β-isomerization of type I collagen degradation products in the urine and aging, menopause and osteoporosis with fractures. Osteoporos Int 9:405-409
14. Peris P, Alvarez L, Monegal A, Guañabens N, Durán M, Echevarría M, Ros I, Ballesta AM, Muñoz Gómez J (2002) Effect of surgical menopause and Paget's bone disease on the degree of isomerization of the type I collagen carboxyterminal telopeptide. Evolution after antiresorptive therapy. J Bone Miner Metab 20:117-112